Optibiotix Health Share Discussion Threads

[elrico] 17/3/2017 15:38

Optiscreen could build up revenues in the region of £20-30m in the future giving a valuation region somewhere between, £200-300m, based on Probiotic market on 10-20x industry. I have previously said, OPTI's strain bank is more robust and diverse, add the crossover value within the 8 strains. IMHO, OPTI is just about to pop its head from the birth canal, while Probi appears to be about to have a midlife crisis.

[riskybusiness1] 17/3/2017 15:13

It's also worth remembering probi is based on probiotics nothing else. No skin division, no optibiotic division (which if continues to deliver the science e.g lpgos will help revolutionise the entire £40+bn industry) and no weight management division.Probi was initially based on 1 strain. A more rational, scientific approach is being applied to Optis lpldl strain whilst using nearly an identical commercial strategy. The probiotic division alone is a potential 10xbagger (obviously not by the end of next week).Once this unfolds and strategy/science/market is spelled out to the masses it should more than make up for a stagnant consolidating 2016 in the coming months.Front page articles such as today about statins seriously widens Optis market and demand for its products.

[diamond fibre] 17/3/2017 15:06

Come on you Spurs, as Elreco and I predicted at the start of the week a 5p gain! Lol

[elrico] 17/3/2017 15:03

Since 2004, PROBI investors have witnessed 13+ years of share price growth, with the odd blip, as you would expect, the biggest blip was for about a month, Sept 2016.

Real momentum for Probi share arrived on the back of....wait for it....acquisition of licenses for two probiotic strains for use in food applications, primarily dairy products. The share price was 128.73 back in march 11th. It has since more than tripled, now pulling back.

Probi (STO:PROB)

Probi has signed an agreement with the Swedish biotech company, Probac, to acquire a license for two probiotic strains for use in food applications, primarily dairy products. The license covers the global market, excluding the Nordic countries. The IP rights for two additional patented strains are included in the agreement, and these will be used for future product development.

Through the agreement, Probi strengthens its offer within the area of Functional Food with specific strains for dairy products. The strains licensed from Probac are based on probiotic research that shows positive effects on the gastrointestinal tract and the immune system. The strains are currently used in the Verum™ range of dairy products, including yoghurt and soured milk, produced by the Norrmejerier dairy company, which owns the rights for the Nordic market.

“We regard this acquisition of new probiotic strains as a great opportunity to grow our Functional Food business area by adding the dairy segment to our offer,” says Peter Nählstedt, CEO of Probi.

The new strains will complement Probi’s existing offer of clinically documented probiotics within the gastro, immune and iron absorption areas. Probi’s strains are used in both Consumer Healthcare products and Functional Food products, including chilled beverages such as ProViva and GoodBelly.

“There is a strong global market potential for functional food with probiotics. These strains have been used in the Verum dairy products for quite some years with proven success, and they will give us the opportunity to develop new product applications,” concludes Peter Nählstedt.

The agreement also includes the IP rights for two thermostable strains, which will enable Probi to extend its offer into new applications in new and growing market segments for probiotics.

This information falls under the obligatory disclosure provisions of the Swedish Securities Market Act and/or the Financial Instruments Trading Act.

[someuwin] 17/3/2017 14:11

Once the next big news comes out (which could easily be next week) we may never see these levels again.

[rafboy] 17/3/2017 13:42

Hope you are right scotty and to think we were higher than this when we didn't have as much behind us as we do now.

[scotty1] 17/3/2017 13:40

Chart wise i would say we look like we are going to attack that £1 mark very soon.

not a prediction jj ;)

[parob] 17/3/2017 13:35

Would be great to break through 80p before the weekend. Would bode very well for Monday.

[chasingprofits] 17/3/2017 13:32

Interesting to see things developing here...

[someuwin] 17/3/2017 13:31

In fact, if you look at the Probi chart you see how they got to their current half billion valuation:

1. A big rise on initial excitement.

2. Followed by an extended period of drifting as peeps are unsure if it will actually happen.

3. Followed by a period of explosive growth as products hit the shelves.

I believe we have had 1 & 2 with OPTI and are about to experience stage 3!

[rafboy] 17/3/2017 13:31

So close, will it be today?

[elrico] 17/3/2017 13:29

I closed my 10,000 NIPT and guess where it went today?

[bobdown2] 17/3/2017 13:10

Thanks for the online situations. My 4000 just changed the bid..

[someuwin] 17/3/2017 13:06

I am convinced we will (in time) surpass Probi's £0.5bn valuation.

i.e. Buy as many as you can. Sit and wait and this could well 10 bag further.

"...The model is quite well-established and investors might want to look at Probi, who established similar models some years ago, they have sales currently of around about £25 million per year, they were last years figures, and their valuation is about half a billion pounds but there are many similarities between ourselves and Probi in terms of their strains and the work they've done with their strains."

[rafboy] 17/3/2017 13:04

This looks ready to move up. Any Chartists have a view?

[owenmo] 17/3/2017 12:57

Can't buy 10,000 online; 5,000 yes @77.9

[whl2] 17/3/2017 12:51

Please, not another Daily Express in the header again !!!

[brucie5] 17/3/2017 12:49

Just come back on board for the umpteenth time.., each one having ended in disappointment. We need to see 80p, the £1 on the chart. That would set us up for a new trading range. Sooner or later.

[parob] 17/3/2017 12:33

One month high on the daily chart...

[rafboy] 17/3/2017 12:24

Right on cue a 20k share sale turns up! Still, looks like we do have buyers today.

[rafboy] 17/3/2017 12:21

Over 60k shares bought on ISDX in the last half hour.

[siennadelekat21] 17/3/2017 12:19

Thanks for that Someuwin.... I just can't figure out how to paste a photo with my IPad on an Advfn board : )CheersSienna

[someuwin] 17/3/2017 12:19

Online buy quote size cut right back.

[siennadelekat21] 17/3/2017 12:05

Nothing that most of us don't really know.... But splashed all over the Daily Express front page today: "STATINS RAISE DIABETES RISK".Nice for us to be seeing headlines like that so close to the launch of products containing CholBiome (every little helps and all that) : )Cheers Sienna